# MONOPAR THERAPEUTICS INC (MNPR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MNPR/

- Reporting holders: 3
- Reported value: $5.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $3.1K | 39 | 0.0% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.9K | 24 | 0.0% | 2 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $239 | 3 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $5.3K |
| Q2 2026 | 97 | $589.4M |
| Q1 2026 | 81 | $342.0M |
| Q4 2025 | 73 | $360.8M |
| Q3 2025 | 55 | $354.4M |
| Q2 2025 | 43 | $113.3M |
| Q1 2025 | 35 | $109.4M |
| Q4 2024 | 18 | $57.1M |
| Q3 2024 | 6 | $105.9K |
| Q2 2024 | 12 | $310.1K |
| Q1 2024 | 15 | $269.1K |
| Q4 2023 | 14 | $92.0K |